BioSpace News Archive

The development in the global health care interoperability solutions market is anticipated to be driven by several factors, such as rising need to reduce the health care costs, increasing focus on patient-centric health care delivery, and rising number of government initiatives aimed at enhancing patient safety and patient care.

Transparency Market Research delivers key insights on the global medical mattress market.

Hansa Biopharma AB “Hansa”, the pioneer in IgG-cleaving enzyme technology for rare immunological conditions, announces that the first patient in its U.S. open-label, randomized, controlled pivotal trial has been enrolled at the Columbia University Medical Center, New York.

Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced the second closing of a $10 million oversubscribed Series A financing.

Collaborative Health Systems (CHS) announced today that its collective support and services have helped Medicare healthcare providers achieve $91 million in total savings through the Next Generation Accountable Care Organization.